Helen Lockhart chairs the firm's Biotechnology Group. Her practice involves strategic counseling on development and management of domestic and international intellectual property rights for a variety of clients, including universities, smaller and mid-sized companies, startups, and entrepreneurs.
Helen has broad experience in prosecuting biotechnology patents relating to immune response modulators, drug delivery, catalytic molecules, antibodies, fluorescence based micro- and nano-analysis, cell culture, mass spectrometry, nucleic acid sequencing, polymer-based and biological-based drug delivery systems, antisense nucleic acid therapeutics, peptides, small molecule mimetics, combinatorial libraries, and drug screening assays. She previously served on the firm’s Executive Committee.
Helen’s doctoral research focused on the regulation of cellular growth and differentiation through signal transduction mechanisms.
"I have been working with Helen Lockhart on a huge portfolio and she is always good. She has a good relationship with our inventor. She helps me because she can call him directly and get what she needs from him so I don’t have to be on those calls."
Helen has been repeatedly named to the list of Massachusetts Super Lawyers in the field of intellectual property law. She is also named one of Massachusetts Super Lawyers’ top 100 Women Attorneys.
In addition, Helen has repeatedly been named a "Life Science Star" by LMG Life Sciences. The LMG Life Sciences guide is based on nearly 1,000 interviews and surveys completed by partners active in the market, interviews with clients and leading lawyers, and review of public information.